Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 190,425 | reported | 03 Feb 2026 | tx 176+6,768,104−1,920,963 |
| Aldeyra Therapeutics, Inc. | 62,728 | reported | 10 Jun 2025 | tx 24+323,513−9,604 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 274,800 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 961,700 | 0.00 USD | deriv |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 63,475 | — | |
| 03 Feb 2026 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 18,611 | 3.47 USD | |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 63,475 | 0.00 USD | deriv |
| 02 Jan 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 29,150 | — | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 9,952 | 2.88 USD | |
| 02 Jan 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 29,150 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 62,728 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 2,413 | 0.00 USD | deriv |
| 01 May 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | — | |
| 01 May 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 2,975 | 1.38 USD | |
| 01 May 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | 0.00 USD | deriv |
| 01 Apr 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 3,042 | 1.48 USD | |
| 01 Apr 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | — | |
| 01 Apr 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | 0.00 USD | deriv |
| 01 Mar 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 3,277 | 1.99 USD | |
| 01 Mar 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,466 | — | |
| 01 Mar 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,466 | 0.00 USD | deriv |
| 01 Feb 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 3,559 | 2.48 USD | |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | — | |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 253,900 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 888,800 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 9,467 | 0.00 USD | deriv |
| 02 Jan 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 13,532 | 2.48 USD |
1 purchase reported after at least 12 months of silence — most recent on 05 Apr 2018.